Lin Jiajia, Ke Lu, Doig Gordon S, Ye Bo, Jiang Zhengying, Liu Zhiyong, Guo Feng, Yin Jiangtao, Yu Wenkui, Sun Jiakui, Sun Liqun, Ding Renyu, Xu Hongyang, Chang Zhigang, Long Yi, Qian Yajun, Tong Zhihui, Li Weiqin
Department of Critical Care Medicine, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
Northern Clinical School, Royal, North Shore Hospital, University of Sydney, Sydney, Australia.
Asia Pac J Clin Nutr. 2021;30(1):15-21. doi: 10.6133/apjcn.202103_30(1).0003.
The novel coronavirus disease (COVID-19) epidemic is spreading all over the world. With the number of cases increasing rapidly, the epidemiological data on the nutritional practice is scarce. In this study, we aim to describe the clinical characteristics and nutritional practice in a cohort of critically ill COVID-19 patients.
This is a multicenter, ambidirectional cohort study conducted at 11 hospitals in Hubei Province, China. All eligible critical COVID-19 patients in the study hospital intensive care units at 00:00, March 6th, 2020, were included. Data collection was performed via written case report forms.
A total of 44 patients were identified and enrolled, of whom eight died during the 28-day outcome follow- up period. The median interval between hospital admission and the study day was 24 (interquartile range, 13- 26) days and 52.2% (23 of 44) of patients were on invasive mechanical ventilation. The median nutrition risk in critically ill (mNUTRIC) score was 3 (interquartile range, 2-5) on the study day. During the enrolment day, 68.2% (30 of 44) of patients received enteral nutrition (EN), while 6.8% (3 of 44) received parenteral nutrition (PN) alone. Nausea and aspiration were uncommon, with a prevalence of 11.4% (5 of 44) and 6.8% (3 of 44), respectively. As for energy delivery, 69.7% (23 of 33) of patients receiving EN and/or PN were achieving their prescribed targets.
The study showed that EN was frequently applied in critical COVID-19 patients. Energy delivery may be suboptimal in this study requiring more attention.
新型冠状病毒肺炎(COVID-19)疫情正在全球蔓延。随着病例数迅速增加,关于营养实践的流行病学数据匮乏。在本研究中,我们旨在描述一组危重症COVID-19患者的临床特征和营养实践情况。
这是一项在中国湖北省11家医院开展的多中心、双向队列研究。纳入2020年3月6日00:00时研究医院重症监护病房内所有符合条件的危重症COVID-19患者。通过书面病例报告表进行数据收集。
共识别并纳入44例患者,其中8例在28天结局随访期内死亡。入院至研究日的中位间隔时间为24天(四分位间距,13 - 26天),52.2%(44例中的23例)患者接受有创机械通气。研究日危重症患者营养风险(mNUTRIC)评分的中位数为3(四分位间距,2 - 5)。在入选当日,68.2%(44例中的30例)患者接受肠内营养(EN),而仅6.8%(44例中的3例)接受肠外营养(PN)。恶心和误吸不常见,患病率分别为11.4%(44例中的5例)和6.8%(44例中的3例)。至于能量供给,接受EN和/或PN的患者中69.7%(33例中的23例)达到了规定目标。
该研究表明EN在危重症COVID-19患者中应用频繁。本研究中能量供给可能未达最佳水平,需要更多关注。